Gilead Sciences · 2 days ago
Associate Director of Consumer Strategy & Activation
Gilead Sciences is dedicated to improving global health by developing therapies for life-threatening illnesses. The Associate Director of Consumer Strategy & Activation will identify and target audiences to enhance engagement and meet brand objectives, utilizing data modeling techniques and strategic audience segmentation.
BiopharmaBiotechnologyHealth CareManufacturingPharmaceutical
Responsibilities
Develop advanced machine learning models and statistical algorithms to create highly-targeted audience segments. Focus on leveraging modeled audience techniques (e.g., 3P LAL, look-alike modeling) based on consumer behaviors, demographics, and other relevant factors to enhance targeting accuracy
Work with cross-functional teams to activate audience segments across digital channels, ensuring that audience strategies align with marketing goals and KPIs
Continuously monitor and optimize audience performance based on campaign results, using data science techniques to improve targeting accuracy and campaign effectiveness
Leverage experience in working with LiveRamp, data clean room environments, or similar platforms to manage and enhance consumer data analysis. Ensure seamless data integration and privacy-compliant collaboration across multiple data sources for more effective audience creation
Ensure data quality and accuracy when leveraging audience data for campaign execution, adhering to best practices in data privacy, governance, and security standards. Handle sensitive healthcare data with utmost care and compliance
Work closely with cross-functional teams including marketing, data analytics, media, and creative, to align audience targeting with campaign strategies, messaging, and creative direction
Qualification
Required
Proven experience in audience segmentation, audience creation, and data-driven marketing, with a focus on leveraging modeled audience techniques such as look-alike modeling (3P LAL), predictive modeling, or other advanced analytics tools to build highly targeted audiences
Advanced proficiency in Python (for data analysis, modeling, and automation)
Strong experience with SQL for data querying and manipulation
Familiarity with integrating and analyzing consumer data from multiple sources (e.g., 1P, 3P claims, SDoH, SFMC) to inform audience creation and activation
Familiarity with privacy regulations, including data protection laws related to consumer and healthcare data
Strong ability to apply data science techniques to uncover insights, solve complex business problems, and improve audience targeting strategies
Bachelor's degree and 10 years of relevant experience, or Master's degree and 8 years of relevant experience, or PhD with 5 years of relevant experience
Preferred
Experience with pharma data and familiarity with platforms such as LiveRamp
Experience working with large-scale consumer data sets and managing audience targeting for media buying and advertising strategies
Expertise in look-alike modeling (3P LAL) to generate high-quality, actionable audience insights for campaign activation
Benefits
Discretionary annual bonus
Discretionary stock-based long-term incentives (eligibility may vary based on role)
Paid time off
Company-sponsored medical, dental, vision, and life insurance plans
Company
Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
H1B Sponsorship
Gilead Sciences has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (269)
2024 (241)
2023 (222)
2022 (208)
2021 (235)
2020 (187)
Funding
Current Stage
Public CompanyTotal Funding
$4.41BKey Investors
Abingworth
2024-11-13Post Ipo Debt· $3.5M
2024-02-29Post Ipo Equity· $210M
2023-09-07Post Ipo Debt· $2B
Leadership Team
Recent News
2026-01-09
2026-01-08
2026-01-07
Company data provided by crunchbase